Companies that are not currently making a profit are intrinsically hard to value.
Buyers of Avita are paying for the potential growth within the current and future total addressable markets.
As long as sales and account numbers continue to grow the share price will return to growth, just a matter of time.
- Forums
- ASX - By Stock
- AVH
- AVH on NASDAQ
AVH on NASDAQ, page-934
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVH (ASX) to my watchlist
(20min delay)
|
|||||
Last
$2.76 |
Change
0.130(4.94%) |
Mkt cap ! $187.9M |
Open | High | Low | Value | Volume |
$2.74 | $2.77 | $2.66 | $1.044M | 382.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 980 | $2.74 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.76 | 10173 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 980 | 2.740 |
3 | 36189 | 2.700 |
1 | 10000 | 2.680 |
3 | 2022 | 2.630 |
1 | 2671 | 2.620 |
Price($) | Vol. | No. |
---|---|---|
2.760 | 10173 | 2 |
2.770 | 17029 | 3 |
2.780 | 1500 | 1 |
2.790 | 3162 | 1 |
2.800 | 2372 | 3 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
AVH (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online